We have located links that may give you full text access.
Epidermal growth factor-like repeats of SCUBE1 derived from platelets are critical for thrombus formation.
Cardiovascular Research 2019 Februrary 6
Aims: SCUBE1 (signal peptide-CUB-EGF domain-containing protein 1), expressed in endothelial cells (ECs) and platelets, exists in soluble or membrane forms. We previously showed that soluble SCUBE1 is a biomarker for platelet activation and also an active participant of thrombosis. However, whether the adhesive module of its EGF-like repeats is essential and the specific contribution of SCUBE1 synthesized in ECs or platelets to thrombosis in vivo remain unclear.
Methods and Results: We generated new mutant (∆2) mice lacking the entire EGF-like repeats to evaluate the module's functional importance during thrombogenesis in vivo. ∆2 platelet-rich plasma showed markedly impaired platelet aggregation induced by agonists including ADP, collagen, the thrombin agonist PAR-4 peptide and the thromboxane A2 analog U46619. Consistently, genetic ablation of the EGF-like repeats diminished arterial thrombosis and protected ∆2 mice against lethal thromboembolism. On flow chamber assay, whole blood isolated from ∆2 or wild-type (WT) mice pretreated with blocking antibodies against the EGF-like repeats showed a significant decrease in platelet deposition and thrombus formation on collagen-coated surfaces under arterial shear rates. Moreover, we created animals expressing SCUBE1 only in ECs (S1-EC) or platelets (S1-PLT) by reciprocal bone-marrow transplantation between WT and ∆2 mice. The time of carotid arterial thrombosis induced by ferric chloride was normal in S1-PLT chimeric mice but much prolonged in S1-EC animals.
Conclusions: We demonstrate that platelet-derived SCUBE1 plays a critical role in arterial thrombosis via its adhesive EGF-like repeats in vivo and suggest targeting these adhesive motifs of SCUBE1 for potential anti-thrombotic strategy.
Methods and Results: We generated new mutant (∆2) mice lacking the entire EGF-like repeats to evaluate the module's functional importance during thrombogenesis in vivo. ∆2 platelet-rich plasma showed markedly impaired platelet aggregation induced by agonists including ADP, collagen, the thrombin agonist PAR-4 peptide and the thromboxane A2 analog U46619. Consistently, genetic ablation of the EGF-like repeats diminished arterial thrombosis and protected ∆2 mice against lethal thromboembolism. On flow chamber assay, whole blood isolated from ∆2 or wild-type (WT) mice pretreated with blocking antibodies against the EGF-like repeats showed a significant decrease in platelet deposition and thrombus formation on collagen-coated surfaces under arterial shear rates. Moreover, we created animals expressing SCUBE1 only in ECs (S1-EC) or platelets (S1-PLT) by reciprocal bone-marrow transplantation between WT and ∆2 mice. The time of carotid arterial thrombosis induced by ferric chloride was normal in S1-PLT chimeric mice but much prolonged in S1-EC animals.
Conclusions: We demonstrate that platelet-derived SCUBE1 plays a critical role in arterial thrombosis via its adhesive EGF-like repeats in vivo and suggest targeting these adhesive motifs of SCUBE1 for potential anti-thrombotic strategy.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app